Melphalan
Melphalan hydrochloride (trade name Alkeran) is a chemotherapy drug belonging to the class of nitrogen mustard alkylating agents. It is used primarily to treat multiple myeloma and ovarian cancer, and occasionally malignant melanoma. Otherwise known as L-Phenylalanine Mustard, or L-PAM, melphalan is a phenylalanine derivative of mechlorethamine. The agent was first investigated as a possible drug for use in melanoma. It did not work, but was found to be of use in myeloma.
Administration
Oral or intravenous; dosing varies by purpose and route of administration as well as patient weight.
Side effects
Common side effects include:
Nausea and vomiting
Bone marrow suppression, including
Decreased white blood cell count causing increased risk of infection
Decreased platelet count causing increased risk of bleeding
Less common side effects include:
Severe allergic reactions
Scarring of lung tissue (usually only with prolonged use)
Hair loss
Rash
Itching
Source: Wikipedia, Melphalan, http://en.wikipedia.org/wiki/Melphalan (as of August 8, 2008).
Related Articles:
- Despite Side Effects, High-Dose Melphalan Remains The Most Effective Dosage In Preparation For Stem Cell Transplantation
- FDA Approves Mozobil For Myeloma Patients Preparing For Stem Cell Transplants
- Velcade-Melphalan-Prednisone-Thalidomide (VMPT) Treatment Is Highly Active In Elderly Myeloma Patients (ASH 2009)
- Managing Steroid-Related Side Effects In Myeloma Patients
- ONJ As A Prognostic Factor In Myeloma Patients Treated With Zometa (ASCO 2009)
Leave a comment